Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre

15 Mar 2021

Abstract excerpt

The demand for genetic testing of hereditary breast cancer genes such as BRCA1 and BRCA2 has continued to increase with the lowering costs of testing, raised awareness in the general public, and implications for breast cancer treatment when a patient is identified as having a germline pathogenic variant. Historically within Australia, patients affected by high genetic risk breast cancers have been referred to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genomics and Rare Diseases
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33723355
DOI: 10.1038/s41431-021-00848-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer CentrePMID 33723355Read ↗

Breast cancer specialists’ experiences and attitudes towards mainstream genetic testing for patients with breast cancerSemantic proximity Read ↗

Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon's practice in a large US Academic Center.Semantic proximity Read ↗

Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testingSemantic proximity Read ↗

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.Semantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

An Australian mainstream genetic testing program: Clinicians views about current and future practicesSemantic proximity Read ↗

An implementation study of the service model for genetic risk-based stratified breast cancer screening – Estonian results of the BRIGHT projectSemantic proximity Read ↗

An overview of genetic services delivery for hereditary breast cancer.Semantic proximity Read ↗

Implementation and Audit of Mainstream Genetic Testing Within a High-Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion.Semantic proximity Read ↗

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.Semantic proximity Read ↗

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.Semantic proximity Read ↗

"It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.